Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours Β· Estimated delivery Aug 24 - Aug 29
Recent advances in therapeutic strategies for triple-negative breast cancer
Results at 72 weeks: Placebo: 3.1% weight loss Tirzepatide 5 mg: 16.0% weight loss (35.3 pounds average) Tirzepatide 10 mg: 21.4% weight loss (49.7 pounds average) Tirzepatide 15 mg: 22.5% weight loss (52.3 pounds average) The percentage of participants achieving 5% or more weight loss was 89% (5 mg), 96% (10 mg), and 96% (15 mg)
Mol Cell Biochem 481 , 911922 (2026)
No anesthesia or preparation is required for the treatment
US$ 26.26
US$ 23.24
US$ 29.18
US$ 23.30
US$ 22.06
US$ 24.74
US$ 29.36
.png)
US$ 21.82
US$ 24.31
US$ 20.78
